Drugs News and Research

RSS

Multifunctional cell therapy system raises hopes to treat inflammatory bowel disease

The research by the UPV/EHU-University of the Basque Country, in collaboration with Harvard University, has yielded highly encouraging results, and studies in animal models have already begun

28 Sep 2020

Researchers study placebo effect in nausea treatment at the molecular level

The molecular bases of the placebo effect are poorly understood. A team led by Ludwig-Maximilians-Universitaet in Munich researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact.

28 Sep 2020

WHO develops new guidelines to prevent mental health conditions among adolescents

New guidelines from WHO recommend a set of psychosocial interventions to promote mental health and prevent mental health conditions among adolescents, aged 10-19 years.

28 Sep 2020

Health on wheels: Tricked-out RVs deliver addiction treatment to rural communities

Tonja Jimenez is far from the only person driving an RV down Colorado's rural highways. But unlike the other rigs, her 34-foot-long motor home is equipped as an addiction treatment clinic on wheels, bringing lifesaving treatment to the northeastern corner of the state, where patients with substance use disorders are often left to fend for themselves.

28 Sep 2020

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureus pneumonia and inflammatory lung damage.

28 Sep 2020

Bacteria-free method for making SARS-CoV-2 infectious clones

Using a circular polymerase chain reaction, researchers have developed a method for making severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant virus, with the ability to introduce mutations. The research by Japanese scientists is published on the preprint server bioRxiv* in September 2020.

27 Sep 2020

Researchers elucidate the impact of genetic mutations in cocaine addiction

Cocaine addiction is a chronic disorder with a high rate of relapse for which no effective treatment is currently available.

26 Sep 2020

Mathematical model helps to better understand the dynamics of interactions between viruses

The framework, published in Frontiers in Microbiology, was applied on transmission data of the influenza virus, and offers to be a new tool for anticipating the consequences of microbial diversity and optimizing disease control measures.

26 Sep 2020

Ascorbic acid: A versatile catalyst for the synthesis of organic compounds

One of the important objectives of green chemistry is the use of eco-friendly solvents and catalysts to perform chemical reactions.

26 Sep 2020

Addressing the impact of COVID-19 pandemic on global mental health

In a special session addressing global mental health before, during and after the COVID-19 pandemic held at the ESCMID Conference on Coronavirus Disease (ECCVID) Professor Vikram Patel H(arvard Medical School, USA) will present a new review of the impact of the COVID-19 pandemic on global mental health.

26 Sep 2020

New study links 160 genes to brain shrinkage

A new study implicates 160 genes in brain shrinkage seen on MRIs of 45,000 healthy adults. The shrinkage is in the cortex, the dimply outer layer of the brain that gives rise to thinking, awareness and action, and largely consists of gray matter.

25 Sep 2020

NIH awards $1.9 million STTR grant to fast track new class of non-opioid pain relievers

The National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) has awarded a $1.9 million Fast-Track Small Business Technology Transfer grant to South Rampart Pharma.

25 Sep 2020

Researchers develop a stable nano-carrier for medications

Medications often have unwanted side-effects. One reason is that they reach not only the unhealthy cells for which they are intended, but also reach and have an impact on healthy cells.

25 Sep 2020

New drug offers hope for young boys with Duchenne muscular dystrophy

A new drug offers hope for young boys with the progressive neuromuscular disease Duchenne muscular dystrophy (DMD) by potentially offering an alternative to high-dose glucocorticoids that have significant side effects.

25 Sep 2020

Study demonstrates a proof-of-concept stem cell treatment in Parkinson's disease mouse model

The mature brain is infamously bad at repairing itself following damage like that caused by trauma or strokes, or from degenerative diseases like Parkinson's. Stem cells, which are endlessly adaptable, have offered the promise of better neural repair.

25 Sep 2020

New approach uses AI to identify which early stage breast cancers will spread

About 1 in 5 new breast cancers are caught at their earliest stages, before they've spread from milk ducts into the surrounding breast tissue.

25 Sep 2020

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

25 Sep 2020

Study identifies potential drug target for dangerous E. coli infections

Escherichia coli, known as E. coli, are bacteria which many people associate with causing mild food poisoning, but some types of E. coli can be fatal.

25 Sep 2020

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.

25 Sep 2020

Study assesses cardiovascular and renal outcomes for ertugliflozin in patients with type 2 diabetes

A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels

25 Sep 2020

Drugs News and Research

Multifunctional cell therapy system raises hopes to treat inflammatory bowel disease

Researchers study placebo effect in nausea treatment at the molecular level

WHO develops new guidelines to prevent mental health conditions among adolescents

Health on wheels: Tricked-out RVs deliver addiction treatment to rural communities

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Bacteria-free method for making SARS-CoV-2 infectious clones

Researchers elucidate the impact of genetic mutations in cocaine addiction

Mathematical model helps to better understand the dynamics of interactions between viruses

Ascorbic acid: A versatile catalyst for the synthesis of organic compounds

Addressing the impact of COVID-19 pandemic on global mental health

New study links 160 genes to brain shrinkage

NIH awards $1.9 million STTR grant to fast track new class of non-opioid pain relievers

Researchers develop a stable nano-carrier for medications

New drug offers hope for young boys with Duchenne muscular dystrophy

Study demonstrates a proof-of-concept stem cell treatment in Parkinson's disease mouse model

New approach uses AI to identify which early stage breast cancers will spread

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Study identifies potential drug target for dangerous E. coli infections

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

Study assesses cardiovascular and renal outcomes for ertugliflozin in patients with type 2 diabetes

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News